Case report
Aug 2026
Pathological Complete Response in a Patient With HER2-Negative Esophagogastric Junction Cancer Undergoing Conversion-Intent Surgery After Ramucirumab Plus Paclitaxel Following Nivolumab-Based Chemotherapy: A Case Report
Y. Yamasaki, Kentaro Miyazaki, Yuta Fujiwara et al.
· Journal of Gastrointestinal... · 0 citations